1
Abiraterone Acetate for Castrate Resistant Prostate Cancer
Condition(s):Prostate CancerLast Updated:April 14, 2020Active, not recruiting
Abiraterone: 329 Clinical Trials, Page 1 of 33
Hide Studies Not Open or Pending
2
Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer
Condition(s):Prostatic NeoplasmsLast Updated:November 18, 2019Recruiting
3
Optimizing Abiraterone Therapy
Condition(s):Metastatic Castration Resistant Prostate CancerLast Updated:September 13, 2019Completed
4
Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer
Condition(s):Prostate CancerLast Updated:September 2, 2020Active, not recruiting
5
Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer
Condition(s):Prostate Cancer Metastatic; Prostate CancerLast Updated:July 2, 2020Recruiting
6
Abiraterone Acetate in Patients With Relapsed and/or Metastatic Salivary Gland Cancers
Condition(s):Salivary Glands TumorsLast Updated:August 23, 2016Unknown status
7
Abiraterone-Rechallenge Study for CRPC Patients
Condition(s):Prostate CancerLast Updated:March 24, 2017Terminated
8
Abiraterone Acetate Trial in African American Prostate Cancer Patients
Condition(s):Prostate CancerLast Updated:May 12, 2017Terminated
9
A Study Designed to Evaluate the Pharmacokinetic Profile of Abiraterone
Condition(s):PharmacokineticsLast Updated:March 4, 2020Completed
10
Activity of Abiraterone Acetate in the Management of Cushing’s Syndrome in Patients With Adrenocortical Carcinoma
Condition(s):Cushing Syndrome; Adrenocortical CarcinomaLast Updated:May 10, 2017Active, not recruiting